{"id":"placebo-drink-moxifloxacin-capsule","safety":{"commonSideEffects":[{"rate":"1-3%","effect":"Nausea"},{"rate":"1-3%","effect":"Diarrhea"},{"rate":"1-2%","effect":"Dizziness"},{"rate":"<1%","effect":"Tendinitis/tendon rupture"},{"rate":"<1%","effect":"QT prolongation"},{"rate":"<1%","effect":"Photosensitivity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Moxifloxacin works by binding to and inhibiting bacterial DNA gyrase (in gram-negative bacteria) and topoisomerase IV (in gram-positive bacteria), enzymes essential for DNA replication and repair. This dual inhibition leads to rapid bactericidal activity against a broad spectrum of aerobic and anaerobic bacteria. The placebo drink component serves as a control vehicle in this formulation.","oneSentence":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible bacteria.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:49.921Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections (respiratory tract, skin and soft tissue, intra-abdominal, complicated skin infections)"}]},"trialDetails":[{"nctId":"NCT07212803","phase":"PHASE4","title":"Effects of Energy Drinks on Cardiovascular Endpoints","status":"RECRUITING","sponsor":"University of the Pacific","startDate":"2025-11-01","conditions":"Healthy Volunteers, Safety After Oral Intake","enrollment":3}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo Drink + Moxifloxacin Capsule","genericName":"Placebo Drink + Moxifloxacin Capsule","companyName":"University of the Pacific","companyId":"university-of-the-pacific","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Moxifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription in susceptible bacteria. Used for Bacterial infections (respiratory tract, skin and soft tissue, intra-abdominal, complicated skin infections).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}